Details of the Drug
General Information of Drug (ID: DM6CBTE)
Drug Name |
3,5-di(pyridin-4-yl)-1H-1,2,4-triazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4329-78-6; CHEMBL1078978; 4,4'-(1H-1,2,4-triazole-3,5-diyl)dipyridine; 3,5-DI(4-pyridyl)-1,2,4-triazole; 3,5-bis(pyridin-4-yl)-1,2,4-triazole; AC1M7KCV; 3,5-di(pyridin-4-yl)-1H-1,2,4-triazole; MLS000999673; 4-(3-pyridin-4-yl-1H-1,2,4-triazol-5-yl)pyridine; SCHEMBL10000033; CTK1D2724; QUKGHTHKDNHSOX-UHFFFAOYSA-; DTXSID00368692; QUKGHTHKDNHSOX-UHFFFAOYSA-N; MolPort-000-263-064; ZINC8048404; BDBM50311280; STK246494; AKOS002269457; AKOS001080808; MCULE-5677308017; 3,5-bis(4-pyridyl)-1,2,4-triazole; SMR000498789; ST092086
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 223.23 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||